India / Nasal Vaccine of Bharat Biotech can be taken as booster dose, will be available on CoWIN platform

Zoom News : Dec 23, 2022, 11:42 AM
Nasal Vaccine Booster: According to sources in the Ministry of Health, Bharat Biotech's Nasal Vaccine will be available on the CoWIN platform from today. Kovid nasal vaccine can be taken as a booster dose. Irrespective of any vaccine, you can take the nasal vaccine as a booster. Currently, Kovid Nasal Vaccine will be available only in private and money will have to be paid for it.

Important meeting of health ministers today

Please tell that the government is in action regarding the Corona crisis. Today there is an important meeting of Health Ministers on the current situation of Corona virus. The Union Health Minister will hold a meeting with the health ministers of the states. Significantly, since the discussion on the new variant, there has been a spurt in the registration of booster doses. At the same time, on Thursday, PM Modi held a review meeting on Corona and said that there is a need to emphasize on increasing genome sequencing.

It is not necessary to wear a mask at the moment

It is reported quoting the sources of the Ministry of Health that at present it is not necessary to wear a mask. Passengers will not be stopped at the airport after sampling. Mock drill will be held in health centers across the country. The situation of Corona in the country is still under control and there is no need to fear about the situation at the moment. However, the cases of corona are increasing rapidly in many countries of the world. That's why precautions are being taken in India from now itself.

Corona outbreak is highest in these countries

The number of active cases of corona has increased in many countries of the world. The number of active cases of corona is more than 19 lakh 50 thousand in America, more than 11 lakh in France, more than 6 lakh 75 thousand in Brazil, 3 thousand 380 in India, more than 1 lakh 24 thousand in Australia and 39 thousand in China and is more than 400.

SUBSCRIBE TO OUR NEWSLETTER